Search Results - eliot+davidowitz

1 Results

Sort By:

  1. Recombinant Antibody Fragments that Selectively Target Oligomeric Tau Aggregates
    Alzheimer's disease (AD) is one of the most prevalent and feared neurodegenerative diseases associated with aging, characterized by progressive neuronal loss and cognitive dysfunction. AD affects nearly 5 million Americans, and unfortunately, there is no cure as of yet. Numerous studies have implicated oligomeric amyloid beta (Aß) aggregates as...
    Published: 2/13/2025
    Inventor(s): Michael Sierks, Huilai Tian, James Moe, Eliot Davidowitz
    Keywords(s): Antibodies, Antibody Therapeutics, Antigen-specific Therapies, Bioassay, Dementias, Diagnostics, Human aging, Protein, Therapeutics
    Category(s): Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Diagnostic Assays/Devices, Medical Diagnostics/Sensors, Proteomic Assays/Reagents/Tools

Search Inventions

Looking for a technology or invention to commercialize? Arizona State University has more than 300 technologies available for licensing. Start your search here or submit your own invention.